Using the Genomics of Drug Sensitivity in Cancer (GDSC) and the Catalogue Of Somatic Mutations In Cancer (COSMIC) databases, we performed high-throughput drug sensitivity screening in lung cancer cell lines according to POLE expression (Fig 1) [20,21]. The gene discussed is POLE; the disease is lung cancer.